1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Prempro: new trials by email Literature Review of Prempro trials Research Report on Prempro
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis bazedoxifene 20 mg/ conjugated estrogens 0.45 mg, bazedoxifene 20 mg/ conjugated estrogens 0.625 mg, bazedoxifene 20 mg - Menopause, Osteoporosis | Phase 3 | Completed | Pfizer | 1886 | 2009-01-01 | 2014-04-08 |
Osteoporosis (1)
Pfizer (1)
Argentina (1) · Australia (1) · Chile (1) · Colombia (1) · Denmark (1) · Finland (1) · Hungary (1) · Mexico (1) · New Zealand (1) · Norway (1) · Poland (1) · United States (1)